RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking preclinical research that supports a nearly ...
At Mariposa Basin Park in Albuquerque, over 700 people took part in the walk to end Alzheimer's. Our very own KOAT sports ...
At SEMERGEN 2025, experts explain how dermocosmetics bridging dermatology and cosmetics can help GPs manage skin concerns, ...
In June 2020, Brody Huber arrived home from a camping trip early, complaining of a headache and insisting he needed a night ...
MedPage Today on MSN
Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer
Among 16 patients with this difficult-to-treat tumor "with few treatment options," the confirmed overall response rate (ORR) ...
It’s no coincidence that conspiracy content thrives online. And it’s little wonder that the grievance-ridden, ...
Austin-Based Supplement Brand Expands Discussion Around Multi-Pathway Neuropathy Support Through Transparent Ingredient Formulation and Research-Led Consumer Education ...
Fast casual concept to celebrate grand opening on November 4, offering free chicken salad for a year ATLANTA, Oct. 28, 2025 ...
Opinion
Health Canada Approval of Lecanemab Offers New Hope for Ontarians Living with Alzheimer's Disease
The Alzheimer Society of Ontario applauds the approval of Lecanemab by Health Canada. This is a historic step forward in the treatment of Alzheimer's disease, and the Alzheimer Society of Ontario ...
New 2025 observational research on adults aged 40-65 finds BurnPeak’s Triple-BHB formulation supports measurable fat reduction, energy balance, and appetite control without stimulants.
Friday, Oct. 24 Hey Day Happy Hour: 4 p.m. Friday and Saturday, Oct. 24-25, at Hey Nonny, 10 S. Vail Ave., Arlington Heights.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback